By showing a critical role for sialylation in the biophysical properties of mucus and mucus transport, the study identifies a possible therapeutic target for the treatment of cystic fibrosis and other muco-obstructive diseases.

The NIH grant will support development of a BionanomatrixTM coating for an aneurysm-therapy flow diverter in the brain.

A cluster analysis in the Deep South showed that racial background significantly influences diabetes subtype distribution.

See the powerful documentary “The Last Ecstatic Days” at UAB's ALys Stephens Center and hear about the cultural and spiritual considerations of dying from UAB caregivers and Aditi Sethi, M.D., with The Center for Conscious Living & Dying, with guest artist Manjari Sharma.

This live biotherapeutic product, tested in mouse models, shows promise in addressing common pathways of lung disease progression.

Researchers at UAB shed light on the link between genetic variants and cardiovascular risk factors in determining heart health.

The novel drug TIX100 functions differently from any approved diabetes drug to promote proper islet cell function.

Researchers at UAB reveal the impact of transthyretin protein levels on heart disease risk.

Research from the centers will help drive new knowledge and foster positive and lasting societal benefits.

This past June, through a competitive review process, the NIH renewed their five-year grant to continue UAB’s Center for AIDS Research pivotal work.  

This study is providing researchers with an infrastructure they can build upon as they work to fully understand how exercise impacts the entire body.

This new device leads to earlier discharge and an overall increase in patient satisfaction.

Indirect benefits could include how to lessen rejection of transplanted organs and damage to the transplanted tissue.

The study will observe two sedation medications, ketamine and etomidate, that are most commonly used for sedations, ketamine and etomidate, to determine which is best during intubations.

Ninety-two percent of evaluable patients treated with INB-200 exceeded a median progression-free survival of seven months. Glioblastoma multiforme is the most aggressive type of cancer originating in the brain.

With more than 3,300 residents living in East Lake, Live HealthSmart Alabama hopes to encourage a healthier lifestyle by providing safe spaces for them to get outside.

Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements after treatment with the monoclonal antibody dupilumab.

The CLA was made possible with support from Coca-Cola United, whose generous donation of $250,000 funded LHSA’s pilot academy.

A newly identified subset of intestinal epithelial cells act as both the major target and a key responder in a mouse model of gut infection by the bacteria Citrobacter rodentium.

Healthcare Decisions Day is April 16, and UAB experts are providing recommendations for how to get started with advance care planning.